Regulation of Mitochondrial Function and its Impact in Metabolic Stress

Current Medicinal Chemistry

Volumn 22, Issue 20, 2015, Pages 2468-2479

  Duarte, Filipe V ^a   Amorim, Joao A ^a   Palmeira, Carlos M ^a,b   Rolo, Anabela P ^a,b  

^a UNIVERSITY OF COIMBRA   (Portugal)

^b UNIVERSITY OF COIMBRA   (Portugal)

Author keywords

AMPK; metabolic diseases; miRNA; mitochondria; Nrf2; oxidative phosphorylation; PGC 1 ; SIRT1

Indexed keywords

ADENOSINE TRIPHOSPHATE; ANTIOXIDANT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; MICRORNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; SIRTUIN 1; TRANSCRIPTION FACTOR NRF2;

ADAPTATION; ARTICLE; BIOENERGY; BIOGENESIS; CELL DISRUPTION; DOWN REGULATION; GENE INDUCTION; GENETIC TRANSCRIPTION; HOMEOSTASIS; HUMAN; METABOLIC STRESS; METABOLISM; MITOCHONDRIAL DYNAMICS; MITOCHONDRIAL GENOME; MITOPHAGY; MOLECULAR STABILITY; NONHUMAN; OXIDATIVE PHOSPHORYLATION; OXIDATIVE STRESS; PROTEIN MODIFICATION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; ANIMAL; MITOCHONDRION;

ANIMALS; HUMANS; MITOCHONDRIA; OXIDATIVE STRESS;

EID: 84938567587     PISSN: 09298673     EISSN: 1875533X     Source Type: Journal    
DOI: 10.2174/0929867322666150514095910     Document Type: Article

References (159)

1. Rolo, A. P.; Palmeira, C. M. Diabetes and mitochondrial function: role of hyperglycemia and oxidative stress. Toxicol. Appl. Pharmacol., 2006, 212, 167-178
2. Wenz, T. PGC-1alpha activation as a therapeutic approach in mitochondrial disease. IUBMB Life, 2009, 61, 1051-1062
3. Wallace, D. C.; Fan, W.; Procaccio, V. Mitochondrial energetics and therapeutics. Annu. Rev. Pathol., 2010, 5, 297-348
4. Rolo, A. P.; Gomes, A. P.; Palmeira, C. M. Regulation of mitochondrial biogenesis in metabolic syndrome. Curr. Drug Targets, 2011, 12, 872-878
5. Kelley, D. E.; He, J.; Menshikova, E. V.; Ritov, V. B. Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes. Diabetes, 2002, 51, 2944-2950
6. Mootha, V. K.; Lindgren, C. M.; Eriksson, K. F.; Subramanian, A.; Sihag, S.; Lehar, J.; Puigserver, P.; Carlsson, E.; Ridderstrale, M.; Laurila, E.; Houstis, N.; Daly, M. J.; Patterson, N.; Mesirov, J. P.; Golub, T. R.; Tamayo, P.; Spiegelman, B.; Lander, E. S.; Hirschhorn, J. N.; Altshuler, D.; Groop, L. C. PGC-1alpharesponsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat. Genet., 2003, 34, 267-273
7. Patti, M. E.; Butte, A. J.; Crunkhorn, S.; Cusi, K.; Berria, R.; Kashyap, S.; Miyazaki, Y.; Kohane, I.; Costello, M.; Saccone, R.; Landaker, E. J.; Goldfine, A. B.; Mun, E.; DeFronzo, R.; Finlayson, J.; Kahn, C. R.; Mandarino, L. J. Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: potential role of PGC1 and NRF1. Proc. Natl. Acad. Sci. U.S.A., 2003, 100, 8466-8471
8. Lowell, B. B.; Shulman, G. I. Mitochondrial dysfunction and type 2 diabetes. Science, 2005, 307, 384-387
9. Crunkhorn, S.; Dearie, F.; Mantzoros, C.; Gami, H.; da Silva, W. S.; Espinoza, D.; Faucette, R.; Barry, K.; Bianco, A. C.; Patti, M. E. Peroxisome proliferator activator receptor gamma coactivator-1 expression Is reduced in obesity: potential pathogenic role of saturated fatty acids and p38 mitogen-activated protein kinase activation. J. Biol. Chem., 2007, 282, 15439-15450
10. Koves, T. R.; Ussher, J. R.; Noland, R. C.; Slentz, D.; Mosedale, M.; Ilkayeva, O.; Bain, J.; Stevens, R.; Dyck, J. R. B.; Newgard, C. B.; Lopaschuk, G. D.; Muoio, D. M. Mitochondrial overload and incomplete fatty acid oxidation contribute to skeletal muscle insulin resistance. Cell Metab., 2008, 7, 45-56
11. Figueiredo, P. A.; Powers, S. K.; Ferreira, R. M.; Appell, H. J.; Duarte, J. A. Aging impairs skeletal muscle mitochondrial bioenergetic function. J. Gerontol. A. Biol. Sci. Med. Sci., 2009, 64, 21-33
12. Samorajski, T.; Friede, R. L.; Ordy, J. M. Age differences in the ultrastructure of axons in the pyramidal tract of the mouse. J. Gerontol., 1971, 26, 542-551
13. Tate, E. L.; Herbener, G. H. A morphometric study of the density of mitochondrial cristae in heart and liver of aging mice. J. Gerontol., 1976, 31, 129-134
14. Liu, C. Y.; Lee, C. F.; Hong, C. H.; Wei, Y. H. Mitochondrial DNA mutation and depletion increase the susceptibility of human cells to apoptosis. Ann. N. Y. Acad. Sci., 2004, 1011, 133-145
15. Linford, N. J.; Beyer, R. P.; Gollahon, K.; Krajcik, R. A.; Malloy, V. L.; Demas, V.; Burmer, G. C.; Rabinovitch, P. S. Transcriptional response to aging and caloric restriction in heart and adipose tissue. Aging Cell, 2007, 6, 673-688
16. Melov, S.; Tarnopolsky, M. A.; Beckman, K.; Felkey, K.; Hubbard, A. Resistance exercise reverses aging in human skeletal muscle. PLoS One, 2007, 2, e465
17. Kujoth, G. C.; Hiona, A.; Pugh, T. D.; Someya, S.; Panzer, K.; Wohlgemuth, S. E.; Hofer, T.; Seo, A. Y.; Sullivan, R.; Jobling, W. A.; Morrow, J. D.; Van Remmen, H.; Sedivy, J. M.; Yamasoba, T.; Tanokura, M.; Weindruch, R.; Leeuwenburgh, C.; Prolla, T. A. Mitochondrial DNA mutations, oxidative stress, and apoptosis in mammalian aging. Science, 2005, 309, 481-484
18. Long, Y. C.; Tan, T. M. C.; Takao, I.; Tang, B. L. The biochemistry and cell biology of aging: metabolic regulation through mitochondrial signaling. Am. J. Physiol. Endocrinol. Metab., 2014, 306, E581-E591
19. Scarpulla, R. C. Transcriptional paradigms in mammalian mitochondrial biogenesis and function. Physiol. Rev., 2008, 88, 611-638
20. Scarpulla, R. C. Nucleus-encoded regulators of mitochondrial function: integration of respiratory chainexpression, nutrient sensing and metabolic stress. Biochim. Biophys. Acta, 2011, 1819, 1088-1097
21. Duarte, F. V.; Palmeira, C. M.; Rolo, A. P. The role of microRNAs in mitochondria: small players acting wide. Genes, 2014, 5, 865-886
22. Barbour, J. A.; Turner, N. Mitochondrial stress signaling promotes cellular adaptations. Int. J. Cell Biol., 2014, 2014, 156020
23. Gottlieb, R. A.; Carreira, R. S. Autophagy in health and disease. 5. mitophagy as a way of life. Am. J. Physiol. Cell Physiol., 2010, 299, C203-C210
24. Kasahara, A.; Scorrano, L. Mitochondria: from cell death executioners to regulators of cell differentiation. Trends Cell Biol., 2014, 24, 761-770
25. Liu, X.; Weaver, D.; Shirihai, O.; Hajnoczky, G. Mitochondrial "kiss-and-run": interplay between mitochondrial motility and fusion-fission dynamics. EMBO J., 2009, 28, 3074-3089
26. Oettinghaus, B.; Licci, M.; Scorrano, L.; Frank, S. Less than perfect divorces: dysregulated mitochondrial fission and neurodegeneration. Acta Neuropathol., 2012, 123, 189-203
27. Chang, C.-R.; Manlandro, C. M.; Arnoult, D.; Stadler, J.; Posey, A. E.; Hill, R. B.; Blackstone, C. A Lethal de novo mutation in the middle domain of the dynamin-related GTPase Drp1 impairs higher order assembly and mitochondrial division. J. Biol. Chem., 2010, 285, 32494-32503
28. Bach, D.; Naon, D.; Pich, S.; Soriano, F. X.; Vega, N.; Rieusset, J.; Laville, M.; Guillet, C.; Boirie, Y.; Wallberg-Henriksson, H.; Manco, M.; Calvani, M.; Castagneto, M.; Palacin, M.; Mingrone, G.; Zierath, J. R.; Vidal, H.; Zorzano, A. Expression of Mfn2, the charcot-marie-tooth neuropathy type 2A gene, in human skeletal muscle: effects of type 2 diabetes, obesity, weight loss, and the regulatory role of tumor necrosis factor alpha and interleukin-6. Diabetes, 2005, 54, 2685-2693
29. Toledo, F. G. S.; Watkins, S.; Kelley, D. E. Changes induced by physical activity and weight loss in the morphology of intermyofibrillar mitochondria in obese men and women. J. Clin. Endocrinol. Metab., 2006, 91, 3224-3227
30. Bach, D.; Pich, S.; Soriano, F. X.; Vega, N.; Baumgartner, B.; Oriola, J.; Daugaard, J. R.; Lloberas, J.; Camps, M.; Zierath, J. R.; Rabasa-Lhoret, R.; Wallberg-Henriksson, H.; Laville, M.; Palacin, M.; Vidal, H.; Rivera, F.; Brand, M.; Zorzano, A. Mitofusin-2 determines mitochondrial network architecture and mitochondrial metabolism: a novel regulatory mechanism altered in obesity. J. Biol. Chem., 2003, 278, 17190-17197
31. Gleyzer, N.; Vercauteren, K.; Scarpulla, R. C. Control of mitochondrial transcription specificity factors (TFB1M and TFB2M) by nuclear respiratory factors (NRF-1 and NRF-2) and PGC-1 family coactivators. Mol. Cell. Biol., 2005, 25, 1354-1366
32. Lin, J.; Wu, H.; Tarr, P. T.; Zhang, C.; Wu, Z. Transcriptional coactivator PGC-1 a drives the formation of slow-twitch muscle fibres. Nature, 2002, 418, 797-801
33. Puigserver, P.; Wu, Z.; Park, C. W.; Graves, R.; Wright, M.; Spiegelma, B. M. A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis. Cell, 1999, 92, 829-839
34. Pilegaard, H.; Saltin, B.; Neufer, P. D. Exercise induces transient transcriptional activation of the PGC-1 gene in human skeletal muscle. J. Physiol., 2003, 546, 851-858
35. Weitzel, J. M.; Iwen, K. A. H.; Seitz, H. J. Regulation of mitochondrial biogenesis by thyroid hormone. Exp. Physiol., 2003, 88, 121-128
36. Kressler, D.; Schreiber, S. N.; Knutti, D.; Kralli, A. The PGC-1-related protein PERC Is a selective coactivator of estrogen receptor alpha. J. Biol. Chem., 2002, 277, 13918-13925
37. Andersson, U.; Scarpulla, R. C. Pgc-1-related coactivator, a novel, serum-inducible coactivator of nuclear respiratory factor 1-dependent transcription in mammalian cells. Mol. Cell. Biol., 2001, 21, 3738-3749
38. Lai, L.; Leone, T. C.; Zechner, C.; Schaeffer, P. J.; Kelly, S. M.; Flanagan, D. P.; Medeiros, D. M.; Kovacs, A.; Kelly, D. P. Transcriptional coactivators PGC-1alpha and PGC-Lbeta control overlapping programs required for erinatal maturation of the heart. Genes Dev., 2008, 22, 1948-1961
39. Zechner, C.; Lai, L.; Zechner, J. F.; Geng, T.; Yan, Z.; Rumsey, J. W.; Collia, D.; Chen, Z.; Wozniak, D. F.; Leone, T. C.; Kelly, D. P. Total skeletal muscle PGC-1 deficiency uncouples mitochondrial derangements from fiber type determination and insulin sensitivity. Cell Metab., 2010, 12, 633-642
40. Gredilla, R.; Barja, G.; Lopez-Torres, M. Effect of short-term caloric restriction on H2O2 production and oxidative DNA damage in rat liver mitochondria and location of the free radical source. J. Bioenerg. Biomembr., 2001, 33, 279-287
41. Sanz, A.; Caro, P.; Ibanez, J.; Gomez, J.; Gredilla, R.; Barja, G. Dietary restriction at old age lowers mitochondrial oxygen radical production and leak at complex I and oxidative DNA damage in rat brain. J. Bioenerg. Biomembr., 2005, 37, 83-90
42. Lopez-Lluch, G.; Hunt, N.; Jones, B.; Zhu, M.; Jamieson, H.; Hilmer, S.; Cascajo, M. V; Allard, J.; Ingram, D. K.; Navas, P.; de Cabo, R. Calorie restriction induces mitochondrial biogenesis and bioenergetic efficiency. Proc. Natl. Acad. Sci. U.S.A., 2006, 103, 1768-1773
43. Ling, C.; Poulsen, P.; Carlsson, E.; Ridderstrale, M.; Almgren, P.; Wojtaszewski, J.; Beck-nielsen, H.; Groop, L.; Vaag, A. Multiple environmental and genetic factors influence skeletal muscle PGC-1 and PGC-1 gene expression in twins. J. Clin. Invest., 2004, 114, 1518-1526
44. Li, F.; Wang, Y.; Zeller, K. I.; Potter, J. J.; Wonsey, D. R.; O'Donnell, K. A.; Kim, J.-W.; Yustein, J. T.; Lee, L. A.; Dang, C. V. Myc stimulates nuclearly encoded mitochondrial genes and mitochondrial biogenesis. Mol. Cell. Biol., 2005, 25, 6225-6234
45. Graves, J. A.; Wang, Y.; Sims-Lucas, S.; Cherok, E.; Rothermund, K.; Branca, M. F.; Elster, J.; Beer-Stolz, D.; Van Houten, B.; Vockley, J.; Prochownik, E. V. Mitochondrial structure, function and dynamics are temporally controlled by c-myc. PLoS One, 2012, 7, e37699
46. Ahuja, P.; Zhao, P.; Angelis, E.; Ruan, H.; Korge, P.; Olson, A.; Wang, Y.; Jin, E. S.; Jeffrey, F. M.; Portman, M.; Maclellan, W. R. Myc controls transcriptional regulation of cardiac metabolism and mitochondrial biogenesis in response to pathological stress in mice. J. Clin. Invest., 2010, 120, 1494-1505
47. Hock, M. B.; Kralli, A. Transcriptional control of mitochondrial biogenesis and function. Annu. Rev. Physiol., 2009, 71, 177-203
48. Canto, C.; Gerhart-Hines, Z.; Feige, J. N.; Lagouge, M.; Noriega, L.; Milne, J. C.; Elliott, P. J.; Puigserver, P.; Auwerx, J. AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity. Nature, 2009, 458, 1056-1060
49. Rodgers, J. T.; Lerin, C.; Haas, W.; Gygi, S. P.; Spiegelman, B. M.; Puigserver, P. Nutrient control of glucose homeostasis through a complex of PGC-1alpha and SIRT1. Nature, 2005, 434, 113-118
50. Gerhart-Hines, Z.; Rodgers, J. T.; Bare, O.; Lerin, C.; Kim, S.-H.; Mostoslavsky, R.; Alt, F. W.; Wu, Z.; Puigserver, P. Metabolic control of muscle mitochondrial function and fatty acid oxidation through SIRT1/PGC-1alpha. EMBO J., 2007, 26, 1913-1923
51. Hubbard, B. P.; Sinclair, D. A. Small molecule SIRT1 activators for the treatment of aging and age-related diseases. Trends Pharmacol. Sci., 2014, 35, 146-154
52. Haigis, M. C.; Sinclair, D. A. Mammalian sirtuins: biological insights and disease relevance. Annu. Rev. Pathol., 2010, 5, 253-295
53. Lim, J.H.; Lee, Y.M.; Chun, Y.S.; Chen, J.; Kim, J.E.; Park, J.W. Sirtuin 1 modulates cellular responses to hypoxia by deacetylating hypoxia-inducible factor 1alpha. Mol. Cell., 2010, 38, 864-878
54. Gomes, A. P.; Price, N. L.; Ling, A. J. Y.; Moslehi, J. J.; Montgomery, M. K.; Rajman, L.; White, J. P.; Teodoro, J. S.; Wrann, C. D.; Hubbard, B. P.; Mercken, E. M.; Palmeira, C. M.; de Cabo, R.; Rolo, A. P.; Turner, N.; Bell, E. L.; Sinclair, D. A. Declining NAD(+) induces a pseudohypoxic state disrupting nuclear-mitochondrial communication during aging. Cell, 2013, 155, 1624-1638
55. Feige, J. N.; Lagouge, M.; Canto, C.; Strehle, A.; Houten, S. M.; Milne, J. C.; Lambert, P. D.; Mataki, C.; Elliott, P. J.; Auwerx, J. Specific SIRT1 activation mimics low energy levels and protects against diet-induced metabolic disorders by enhancing fat oxidation. Cell Metab., 2008, 8, 347-358
56. Lagouge, M.; Argmann, C.; Gerhart-Hines, Z.; Meziane, H.; Lerin, C.; Daussin, F.; Messadeq, N.; Milne, J.; Lambert, P.; Elliott, P.; Geny, B.; Laakso, M.; Puigserver, P.; Auwerx, J. Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha. Cell, 2006, 127, 1109-1122
57. Purushotham, A.; Schug, T. T.; Xu, Q.; Surapureddi, S.; Guo, X.; Li, X. Hepatocyte-specific deletion of SIRT1 alters fatty acid metabolism and results in hepatic steatosis and inflammation. Cell Metab., 2009, 9, 327-338
58. Baur, J. A.; Sinclair, D. A. Therapeutic potential of resveratrol: the in Vvvo evidence. Nat. Rev. Drug. Discov., 2006, 5, 493-506
59. Price, N. L.; Gomes, A. P.; Ling, A. J.; Duarte, F. V; Martin-Montalvo, A.; North, B. J.; Agarwal, B.; Ye, L.; Ramadori, G.; Teodoro, J. S.; Hubbard, B. P.; Varela, A. T.; Davis, J. G.; Varamini, B.; Hafner, A.; Moaddel, R.; Rolo, A. P.; Coppari, R.; Palmeira, C. M.; de Cabo, R.; Baur, J. A.; Sinclair, D. A. SIRT1 Is required for AMPK activation and the beneficial effects of resveratrol on mitochondrial function. Cell Metab., 2012, 15, 675-690
60. Cohen, H. Y.; Miller, C.; Bitterman, K. J.; Wall, N. R.; Hekking, B.; Kessler, B.; Howitz, K. T.; Gorospe, M.; de Cabo, R.; Sinclair, D. A. Calorie restriction promotes mammalian cell survival by inducing the SIRT1 deacetylase. Science, 2004, 305, 390-392
61. Hsu, C. P.; Hariharan, N.; Alcendor, R. R.; Oka, S.; Sadoshima, J. Nicotinamide phosphoribosyltransferase regulates cell survival through autophagy in cardiomyocytes. Autophagy, 2009, 5, 1229-1231
62. Jang, S.-Y.; Kang, H. T.; Hwang, E. S. Nicotinamide-induced mitophagy: event mediated by high NAD+/NADH ratio and SIRT1 protein activation. J. Biol. Chem., 2012, 287, 19304-19314
63. Canto, C.; Auwerx, J. Targeting sirtuin 1 to improve metabolism: all you need is NAD(+) Pharmacol. Rev., 2012, 64, 166-187
64. Shaw, R. J.; Kosmatka, M.; Bardeesy, N.; Hurley, R. L.; Witters, L. A.; DePinho, R. A.; Cantley, L. C. The tumor suppressor LKB1 kinase directly activates AMP-activated kinase and regulates apoptosis in response to energy stress. Proc. Natl. Acad. Sci. U.S.A., 2004, 101, 3329-3335
65. Canto, C.; Jiang, L. Q.; Deshmukh, A. S.; Mataki, C.; Coste, A.; Lagouge, M.; Zierath, J. R.; Auwerx, J. Interdependence of AMPK and SIRT1 for metabolic adaptation to fasting and exercise in skeletal muscle. Cell Metab., 2010, 11, 213-219
66. Lan, F.; Cacicedo, J. M.; Ruderman, N.; Ido, Y. SIRT1 modulation of the acetylation status, cytosolic localization, and activity of LKB1. possible role in AMP-activated protein kinase activation. J. Biol. Chem., 2008, 283, 27628-27635
67. Motohashi, H.; Yamamoto, M. Nrf2-Keap1 defines a physiologically important stress response mechanism. Trends Mol. Med., 2004, 10, 549-557
68. Jaiswal, A. K. Regulation of antioxidant response elementdependent induction of detoxifying enzyme synthesis. Methods Enzym., 2004, 378, 221-238
69. Venugopal, R.; Jaiswal, A. K. Nrf1 and Nrf2 positively and c-Fos and fra1 negatively regulate the human antioxidant response element-mediated expression of NAD(P)H:quinone oxidoreductase1 Gene. Proc. Natl. Acad. Sci. U.S.A., 1996, 93, 14960-14965
70. Alam, J.; Igarashi, K.; Immenschuh, S.; Shibahara, S.; Tyrrell, R. M. Regulation of heme oxygenase-1 gene transcription: recent advances and highlights from the international conference (Uppsala, 2003) on heme oxygenase. Antioxid. Redox Signal., 2004, 6, 924-933
71. Kobayashi, M.; Yamamoto, M. Molecular mechanisms activating the Nrf2-Keap1 pathway of antioxidant gene regulation. Antioxid. Redox Signal., 2005, 7, 385-394
72. Piantadosi, C. A.; Carraway, M. S.; Babiker, A.; Suliman, H. B. Heme oxygenase-1 regulates cardiac mitochondrial biogenesis via Nrf2-mediated transcriptional control of nuclear respiratory factor-1. Circ. Res., 2008, 103, 1232-1240
73. Lee, O.-H.; Jain, A. K.; Papusha, V.; Jaiswal, A. K. An autoregulatory loop between Stress sensors INrf2 and Nrf2 controls their cellular abundance. J. Biol. Chem., 2007, 282, 36412-36420
74. Itoh, K.; Tong, K. I.; Yamamoto, M. Molecular mechanism activating Nrf2-Keap1 pathway in regulation of adaptive response to electrophiles. Free Radic. Biol. Med., 2004, 36, 1208-1213
75. Nguyen, T.; Sherratt, P. J.; Nioi, P.; Yang, C. S.; Pickett, C. B. Nrf2 controls constitutive and inducible expression of ARE-driven genes through a dynamic pathway involving nucleocytoplasmic shuttling by Keap1. J. Biol. Chem., 2005, 280, 32485-32492
76. Rusten, T. E.; Stenmark, H. p62, an autophagy hero or culprit Nat. Cell. Biol., 2010, 12, 207 209
77. Komatsu, M.; Kurokawa, H.; Waguri, S.; Taguchi, K.; Kobayashi, A.; Ichimura, Y.; Sou, Y.-S.; Ueno, I.; Sakamoto, A.; Tong, K. I.; Kim, M.; Nishito, Y.; Iemura, S.; Natsume, T.; Ueno, T.; Kominami, E.; Motohashi, H.; Tanaka, K.; Yamamoto, M. The selective autophagy substrate p62 activates the stress responsive transcription factor Nrf2 through inactivation of Keap1. Nat. Cell. Biol., 2010, 12, 213-223
78. Lau, A.; Wang, X.-J.; Zhao, F.; Villeneuve, N. F.; Wu, T.; Jiang, T.; Sun, Z.; White, E.; Zhang, D. D. A noncanonical mechanism of nrf2 activation by autophagy deficiency: direct interaction between Keap1 and p62. Mol. Cell. Biol., 2010, 30, 3275-3285
79. Zhang, Y.-K. J.; Wu, K. C.; Klaassen, C. D. Genetic activation of Nrf2 protects against fasting-induced oxidative stress in livers of mice. PloS One, 2013, 8, e59122
80. Kim, T.-H.; Hur, E.-G.; Kang, S.-J.; Kim, J.-A.; Thapa, D.; Lee, Y. M.; Ku, S. K.; Jung, Y.; Kwak, M.-K. NRF2 blockade suppresses colon tumor angiogenesis by inhibiting hypoxia-induced activation of HIF-1. Cancer Res., 2011, 71, 2260-2275
81. Holmstrom, K. M.; Baird, L.; Zhang, Y.; Hargreaves, I.; Chalasani, A.; Land, J. M.; Stanyer, L.; Yamamoto, M.; Dinkova-Kostova, A. T.; Abramov, A. Y. Nrf2 impacts cellular bioenergetics by controlling substrate availability for mitochondrial respiration. Biol. Open., 2013, 2, 761-770
82. Lee, J.-M.; Shih, A. Y.; Murphy, T. H.; Johnson, J. A. NF-E2-related factor-2 mediates neuroprotection against mitochondrial complex I inhibitors and increased concentrations of intracellular calcium in primary cortical neurons. J. Biol. Chem., 2003, 278, 37948-37956
83. Pehar, M.; Vargas, M. R.; Robinson, K. M.; Cassina, P.; Diaz-Amarilla, P. J.; Hagen, T. M.; Radi, R.; Barbeito, L.; Beckman, J. S. Mitochondrial superoxide production and nuclear factor erythroid 2-related factor 2 activation in p75 neurotrophin receptorinduced motor neuron apoptosis. J. Neurosci., 2007, 27, 7777-7785
84. Greco, T.; Fiskum, G. Brain Mitochondria from rats treated with sulforaphane are resistant to redox-regulated permeability transition. J. Bioenerg. Biomembr., 2010, 42, 491-497
85. Molina-Jijon, E.; Tapia, E.; Zazueta, C.; El Hafidi, M.; Zatarain-Barron, Z. L.; Hernandez-Pando, R.; Medina-Campos, O. N.; Zarco-Marquez, G.; Torres, I.; Pedraza-Chaverri, J. Curcumin prevents Cr(VI)-induced renal oxidant damage by a mitochondrial pathway. Free Radic. Biol. Med., 2011, 51, 1543-1557
86. MacGarvey, N. C.; Suliman, H. B.; Bartz, R. R.; Fu, P.; Withers, C. M.; Welty-Wolf, K. E.; Piantadosi, C. A. Activation of mitochondrial biogenesis by heme oxygenase-1-mediated NF-E2-related factor-2 induction rescues mice from lethal staphylococcus aureus sepsis. Am. J. Respir. Crit. Care Med., 2012, 185, 851-861
87. Yang, L.; Calingasan, N. Y.; Thomas, B.; Chaturvedi, R. K.; Kiaei, M.; Wille, E. J.; Liby, K. T.; Williams, C.; Royce, D.; Risingsong, R.; Musiek, E. S.; Morrow, J. D.; Sporn, M.; Beal, M. F. Neuroprotective effects of the triterpenoid, CDDO methyl amide, a potent inducer of Nrf2-mediated transcription. PLoS One, 2009, 4, e5757
88. Gomes, A. P.; Duarte, F. V.; Nunes, P.; Hubbard, B. P.; Teodoro, J. S.; Varela, A. T.; Jones, J. G.; Sinclair, D. A.; Palmeira, C. M.; Rolo, A. P. Berberine protects against high fat diet-induced dysfunction in muscle mitochondria by inducing SIRT1-dependent mitochondrial biogenesis. Biochim. Biophys. Acta., 2012, 1822, 185-195
89. Hsu, Y.Y.; Chen, C.S.; Wu, S.N.; Jong, Y.J.; Lo, Y.C. Berberine activates Nrf2 nuclear translocation and protects against oxidative damage via a phosphatidylinositol 3-kinase/Akt-dependent mechanism in NSC34 motor neuron-like Cells. Eur. J. Pharmacol. Sci., 2012, 46, 415-425
90. Jin, Y. N.; Yu, Y. V; Gundemir, S.; Jo, C.; Cui, M.; Tieu, K.; Johnson, G. V. W. Impaired mitochondrial dynamics and Nrf2 signaling contribute to compromised responses to oxidative stress in striatal cells expressing full-length mutant huntingtin. PLoS One, 2013, 8, e57932
91. Mitsuishi, Y.; Taguchi, K.; Kawatani, Y.; Shibata, T.; Nukiwa, T.; Aburatani, H.; Yamamoto, M.; Motohashi, H. Nrf2 redirects glucose and glutamine into anabolic pathways in metabolic reprogramming. Cancer Cell, 2012, 22, 66-79
92. Yates, M. S.; Tran, Q. T.; Dolan, P. M.; Osburn, W. O.; Shin, S.; McCulloch, C. C.; Silkworth, J. B.; Taguchi, K.; Yamamoto, M.; Williams, C. R.; Liby, K. T.; Sporn, M. B.; Sutter, T. R.; Kensler, T. W. Genetic versus chemoprotective activation of Nrf2 signaling: overlapping yet distinct gene expression profiles between keap1 knockout and triterpenoid-treated mice. Carcinogenesis, 2009, 30, 1024-1031
93. Kitteringham, N. R.; Abdullah, A.; Walsh, J.; Randle, L.; Jenkins, R. E.; Sison, R.; Goldring, C. E.; Powell, H.; Sanderson, C.; Williams, S.; Higgins, L.; Yamamoto, M.; Hayes, J.; Park, B. K. Proteomic analysis of Nrf2 deficient transgenic mice reveals cellular defence and lipid metabolism as primary Nrf2-dependent pathways in the liver. J. Proteomics, 2010, 73, 1612-1631
94. Tanaka, Y.; Aleksunes, L. M.; Yeager, R. L.; Gyamfi, M. A.; Esterly, N.; Guo, G. L.; Klaassen, C. D. NF-E2-related factor 2 inhibits lipid accumulation and oxidative stress in mice fed a highfat Diet. J. Pharmacol. Exp. Ther., 2008, 325, 655-664
95. He, X.; Kan, H.; Cai, L.; Ma, Q. Nrf2 Is critical in defense against high glucose-induced oxidative damage in ardiomyocytes. J. Mol. Cell Cardiol., 2009, 46, 47-58
96. Tan, Y.; Ichikawa, T.; Li, J.; Si, Q.; Yang, H.; Chen, X.; Goldblatt, C. S.; Meyer, C. J.; Li, X.; Cai, L.; Cui, T. Diabetic downregulation of Nrf2 activity via ERK contributes to oxidative stress-induced insulin resistance in cardiac cells in vitro and in vivo. Diabetes, 2011, 60, 625-633
97. Ungvari, Z.; Bagi, Z.; Feher, A.; Recchia, F. A.; Sonntag, W. E.; Pearson, K.; de Cabo, R.; Csiszar, A. Resveratrol confers endothelial protection via activation of the antioxidant transcription factor Nrf2. Am. J. Physiol. Hear. Circ. Physiol., 2010, 299, H18-H24
98. Aleksunes, L. M.; Reisman, S. A.; Yeager, R. L.; Goedken, M. J.; Klaassen, C. D. Nuclear factor erythroid 2-related factor 2 deletion impairs glucose tolerance and exacerbates hyperglycemia in type 1 diabetic mice. J. Pharmacol. Exp. Ther., 2010, 333, 140-151
99. Zhang, Y.-K. J.; Yeager, R. L.; Tanaka, Y.; Klaassen, C. D. Enhanced expression of Nrf2 in mice attenuates the fatty liver produced by a methionine-and choline-deficient diet. Toxicol. Appl. Pharmacol., 2010, 245, 326-334
100. Shin, S.; Wakabayashi, J.; Yates, M. S.; Wakabayashi, N.; Dolan, P. M.; Aja, S.; Liby, K. T.; Sporn, M. B.; Yamamoto, M.; Kensler, T. W. Role of Nrf2 in prevention of high-fat diet-induced obesity by synthetic triterpenoid CDDO-imidazolide. Eur. J. Pharmacol., 2009, 620, 138-144
101. Yu, Z.; Shao, W.; Chiang, Y.; Foltz, W.; Zhang, Z.; Ling, W.; Fantus, I. G.; Jin, T. Oltipraz upregulates the nuclear factor (erythroid-derived 2)-like 2 [corrected](NRF2) antioxidant system and prevents insulin resistance and obesity induced by a high-fat diet in C57BL/6J mice. Diabetologia, 2011, 54, 922-934
102. Lee, C. S.; Ho, D. V; Chan, J. Y. Nuclear factor-erythroid 2-related factor 1 regulates expression of proteasome genes in hepatocytes and protects against endoplasmic reticulum stress and steatosis in mice. FEBS J., 2013, 280, 3609-3620
103. Zhang, Y.-K. J.; Wu, K. C.; Liu, J.; Klaassen, C. D. Nrf2 deficiency improves glucose tolerance in mice fed a high-fat diet. Toxicol. Appl. Pharmacol., 2012, 264, 305-314
104. Pi, J.; Leung, L.; Xue, P.; Wang, W.; Hou, Y.; Liu, D.; Yehuda-Shnaidman, E.; Lee, C.; Lau, J.; Kurtz, T. W.; Chan, J. Y. Deficiency in the nuclear factor E2-related factor-2 transcription factor results in impaired adipogenesis and protects against dietinduced obesity. J. Biol. Chem., 2010, 285, 9292-9300
105. Taguchi, K.; Fujikawa, N.; Komatsu, M.; Ishii, T.; Unno, M.; Akaike, T.; Motohashi, H.; Yamamoto, M. Keap1 degradation by autophagy for the maintenance of redox homeostasis. Proc. Natl. Acad. Sci. U.S.A., 2012, 109, 13561-13566
106. Sachdeva, M. M.; Cano, M.; Handa, J. T. Nrf2 signaling is impaired in the aging RPE given an oxidative insult. Exp. Eye Res., 2014, 119, 111-114
107. Sykiotis, G. P.; Bohmann, D. Keap1/Nrf2 signaling regulates oxidative stress tolerance and lifespan in drosophila. Dev. Cell, 2008, 14, 76-85
108. Shin, B. Y.; Jin, S. H.; Cho, I. J.; Ki, S. H. Nrf2-ARE pathway regulates induction of sestrin-2 expression. Free Radic. Biol. Med., 2012, 53, 834-841
109. Bae, S. H.; Sung, S. H.; Oh, S. Y.; Lim, J. M.; Lee, S. K.; Park, Y. N.; Lee, H. E.; Kang, D.; Rhee, S. G. Sestrins activate Nrf2 by promoting p62-dependent autophagic degradation of keap1 and prevent oxidative liver damage. Cell Metab., 2013, 17, 73-84
110. Budanov, A. V; Sablina, A. A.; Feinstein, E.; Koonin, E. V; Chumakov, P. M. Regeneration of peroxiredoxins by p53-regulated sestrins, homologs of bacterial AhpD. Science, 2004, 304, 596-600
111. Budanov, A. V; Karin, M. P53 target genes sestrin1 and sestrin2 connect genotoxic stress and mTOR signaling. Cell, 2008, 134, 451-460
112. Lee, J. H.; Budanov, A. V; Park, E. J.; Birse, R.; Kim, T. E.; Perkins, G. A.; Ocorr, K.; Ellisman, M. H.; Bodmer, R.; Bier, E.; Karin, M. Sestrin as a feedback inhibitor of TOR that prevents agerelated pathologies. Science, 2010, 327, 1223-1228
113. Sanli, T.; Linher-Melville, K.; Tsakiridis, T.; Singh, G. Sestrin2 modulates AMPK subunit expression and its response to ionizing radiation in breast cancer cells. PLoS One, 2012, 7, e32035
114. Ben-Sahra, I.; Dirat, B.; Laurent, K.; Puissant, A.; Auberger, P.; Budanov, A.; Tanti, J.-F.; Bost, F. Sestrin2 integrates akt and mTOR signaling to protect cells against energetic stress-induced death. Cell Death Differ., 2013, 20, 611-619
115. Yamamoto, H.; Morino, K.; Nishio, Y.; Ugi, S.; Yoshizaki, T.; Kashiwagi, A.; Maegawa, H. MicroRNA-494 regulates mitochondrial biogenesis in skeletal muscle through mitochondrial transcription factor A and forkhead box j3. Am. J. Physiol. Endocrinol. Metab., 2012, 303, E1419-E1427
116. Tetreault, N.; De Guire, V. miRNAs: Their discovery, biogenesis and mechanism of action. Clin. Biochem., 2013, 46, 842-845
117. Zhu, H.; Wu, H.; Liu, X.; Li, B.; Chen, Y.; Ren, X.; Liu, C.; Yang, J. Regulation of autophagy by a beclin 1-targeted microRNA, miR-30a, in Cancer Cells. Autophagy, 2009, 5, 816-823
118. Bandiera, S.; Ruberg, S.; Girard, M.; Cagnard, N.; Hanein, S.; Chretien, D.; Munnich, A.; Lyonnet, S.; Henrion-Caude, A. Nuclear outsourcing of RNA interference components to human mitochondria. PLoS One, 2011, 6, e20746
119. Frankel, L. B.; Wen, J.; Lees, M.; Hoyer-Hansen, M.; Farkas, T.; Krogh, A.; Jaattela, M.; Lund, A. H. microRNA-101 is a potent inhibitor of autophagy. EMBO J., 2011, 30, 4628-4641
120. Sripada, L.; Tomar, D.; Singh, R. Mitochondria: One of the destinations of miRNAs. Mitochondrion, 2012, 12, 593-599
121. Xiao, J.; Zhu, X.; He, B.; Zhang, Y.; Kang, B.; Wang, Z.; Ni, X. MiR-204 regulates cardiomyocyte autophagy induced by ischemiareperfusion through LC3-II. J. Biomed. Sci., 2011, 18, 35
122. Bienertova-Vasku, J.; Sana, J.; Slaby, O. The role of microRNAs in mitochondria in cancer. Cancer Lett., 2013, 336, 1-7
123. Wegner, M.; Neddermann, D.; Piorunska-Stolzmann, M.; Jagodzinski, P. P. Role of epigenetic mechanisms in the development of chronic complications of diabetes. Diabetes Res. Clin. Pract., 2014, 105, 164-175
124. Rottiers, V.; Naar, A. M. MicroRNAs in metabolism and metabolic disorders. Nat. Rev. Mol. Cell Biol., 2012, 13, 239-250
125. Koch, L. Paediatrics: circulating microRNAs-predictors of obesity Nat. Rev. Endocrinol., 2013, 9, 565
126. Pescador, N.; Perez-Barba, M.; Ibarra, J. M.; Corbaton, A.; Martinez-Larrad, M. T.; Serrano-Rios, M. Serum circulating microRNA profiling for identification of potential type 2 diabetes and obesity biomarkers. PLoS One, 2013, 8, e77251
127. Ye, Q.; Zhao, X.; Xu, K.; Li, Q.; Cheng, J.; Gao, Y.; Du, J.; Shi, H.; Zhou, L. Polymorphisms in lipid metabolism related miRNA binding sites and risk of metabolics yndrome. Gene, 2013, 528, 132-138
128. Liang, T.; Liu, C.; Ye, Z. Deep sequencing of small RNA repertoires in mice reveals metabolic disorders-associated hepatic miRNAs. PLoS One, 2013, 8, e80774
129. Civelek, M.; Hagopian, R.; Pan, C.; Che, N.; Yang, W.-P.; Kayne, P. S.; Saleem, N. K.; Cederberg, H.; Kuusisto, J.; Gargalovic, P. S.; Kirchgessner, T. G.; Laakso, M.; Lusis, A. J. Genetic regulation of human adipose microRNA expression and Its consequences for metabolic traits. Hum. Mol. Genet., 2013, 22, 3023-3037
130. Najafi-Shoushtari, S. H.; Kristo, F.; Li, Y.; Shioda, T.; Cohen, D. E.; Gerszten, R. E.; Naar, A. M. MicroRNA-33 and the SREBP host genes cooperate to control cholesterol homeostasis. Science, 2010, 328, 1566-1569
131. Trajkovski, M.; Hausser, J.; Soutschek, J.; Bhat, B.; Akin, A.; Zavolan, M.; Heim, M. H.; Stoffel, M. MicroRNAs 103 and 107 regulate insulin sensitivity. Nature, 2011, 474, 649-653
132. Zhu, H.; Shyh-Chang, N.; Segre, A. V; Shinoda, G.; Shah, S. P.; Einhorn, W. S.; Takeuchi, A.; Engreitz, J. M.; Hagan, J. P.; Kharas, M. G.; Urbach, A.; Thornton, J. E.; Triboulet, R.; Gregory, R. I.; Altshuler, D.; Daley, G. Q. The Lin28/let-7 axis regulates glucose metabolism. Cell, 2011, 147, 81-94
133. Frost, R. J. A.; Olson, E. N. Control of glucose homeostasis and insulin sensitivity by the let-7 family of microRNAs. Proc. Natl. Acad. Sci. U.S.A., 2011, 108, 21075-21080
134. Grueter, C. E.; van Rooij, E.; Johnson, B. A.; DeLeon, S. M.; Sutherland, L. B.; Qi, X.; Gautron, L.; Elmquist, J. K.; Bassel-Duby, R.; Olson, E. N. A Cardiac microRNA governs systemic energy homeostasis by regulation of MED13. Cell, 2012, 149, 671-683
135. Zhang, J.-G.; Wang, J.-J.; Zhao, F.; Liu, Q.; Jiang, K.; Yang, G.-H. MicroRNA-21 (miR-21) represses tumor suppressor PTEN and promotes growth and invasion in non-small cell lung cancer (NSCLC). Clin. Chim. Acta., 2010, 411, 846-852
136. Mohamed, J. S.; Hajira, A.; Pardo, P. S.; Boriek, A. M. MicroRNA-149 inhibits PARP-2 and promotes mitochondrial biogenesis via SIRT-1/PGC-1 network in skeletal muscle. Diabetes, 2014, 63, 1546-1559
137. Carrer, M.; Liu, N.; Grueter, C. E.; Williams, A. H.; Frisard, M. I.; Hulver, M. W.; Bassel-Duby, R.; Olson, E. N. Control of mitochondrial metabolism and systemic energy homeostasis by microRNAs 378 and 378. Proc. Natl. Acad. Sci. U.S.A., 2012, 109, 15330-15335
138. Nishi, H.; Ono, K.; Iwanaga, Y.; Horie, T.; Nagao, K.; Takemura, G.; Kinoshita, M.; Kuwabara, Y.; Mori, R. T.; Hasegawa, K.; Kita, T.; Kimura, T. MicroRNA-15b modulates cellular ATP levels and degenerates mitochondria via Arl2 in neonatal rat cardiac myocytes. J. Biol. Chem., 2010, 285, 4920-4930
139. Tomasetti, M.; Neuzil, J.; Dong, L. MicroRNAs as regulators of mitochondrial function: Role in cancer suppression. Biochim. Biophys. Acta., 2013, 1840, 1441-1453
140. Aschrafi, A.; Schwechter, A. D.; Mameza, M. G.; Natera-Naranjo, O.; Gioio, A. E.; Kaplan, B. B. MicroRNA-338 regulates local cytochrome c oxidase IV mRNA levels and oxidative phosphorylation in the axons of sympathetic neurons. J. Neurosci., 2008, 28, 12581-12590
141. Das, S.; Ferlito, M.; Kent, O. A.; Fox-Talbot, K.; Wang, R.; Liu, D.; Raghavachari, N.; Yang, Y.; Wheelan, S. J.; Murphy, E.; Steenbergen, C. Nuclear miRNA regulates the mitochondrial genome in the heart. Circ. Res., 2012, 110, 1596-1603
142. Das, S.; Bedja, D.; Campbell, N.; Dunkerly, B.; Chenna, V.; Maitra, A.; Steenbergen, C. miR-181c regulates the mitochondrial genome, bioenergetics, and propensity for heart failure in vivo. PLoS One, 2014, 9, e96820
143. Wang, L.; Huang, H.; Fan, Y.; Kong, B.; Hu, H.; Hu, K.; Guo, J.; Mei, Y.; Liu, W. Effects of downregulation of microRNA-181a on H2O2-induced H9c2 Cell apoptosis via the mitochondrial apoptotic pathway. Oxid. Med. Cell. Longev., 2014, 2014, 960362
144. Karbiener, M.; Pisani, D.; Frontini, A.; Oberreiter, L.; Lang, E.; Vegiopoulos, A.; Mossenbock, K.; Bernhardt, G.; Mayr, T.; Hildner, F.; Grillari, J.; Ailhaud, G.; Herzig, S.; Cinti, S.; Amri, E.; Scheideler, M. MicroRNA-26 family Is required for human adipogenesis and drives characteristics of brown adipocytes. Stem Cells, 2014, 32, 1578-1590
145. Kang, T.; Lu, W.; Xu, W.; Anderson, L.; Bacanamwo, M.; Thompson, W.; Chen, Y. E.; Liu, D. MicroRNA-27 (miR-27) targets prohibitin and impairs adipocyte differentiation and mitochondrial function in human adipose-derived stem cells. J. Biol. Chem., 2013, 288, 34394-34402
146. Frankel, L. B.; Lund, A. H. MicroRNA regulation of autophagy. Carcinogenesis, 2012, 33, 2018-2025
147. Long, B.; Wang, K.; Li, N.; Murtaza, I.; Xiao, J.-Y.; Fan, Y.-Y.; Liu, C.-Y.; Li, W.-H.; Cheng, Z.; Li, P. miR-761 regulates the mitochondrial network by targeting mitochondrial fission factor. Free Radic. Biol. Med., 2013, 65C, 371-379
148. Li, J.; Donath, S.; Li, Y.; Qin, D.; Prabhakar, B. S.; Li, P. miR-30 regulates mitochondrial fission through targeting p53 and the dynamin-related protein-1 pathway. PLoS Genet., 2010, 6, e1000795
149. Li, J.; Li, Y.; Jiao, J.; Wang, J.; Li, Y.; Qin, D.; Li, P. Mitofusin 1 Is negatively regulated by microRNA 140 in cardiomyocyte apoptosis. Mol. Cell. Biol., 2014, 34, 1788-1799
150. Wang, K.; Long, B.; Jiao, J.-Q.; Wang, J.-X.; Liu, J.-P.; Li, Q.; Li, P.-F. miR-484 regulates mitochondrial network through targeting fis1. Nat. Commun., 2012, 3, 781
151. Yoon, Y.; Galloway, C. A.; Jhun, B. S.; Yu, T. Mitochondrial dynamics in diabetes. Antioxid. Redox Signal., 2011, 14, 439-457
152. Hanahan, D.; Weinberg, R. A. The hallmarks of cancer. Cell, 2000, 100, 57-70
153. Hanahan, D.; Weinberg, R. A. Hallmarks of cancer: The next generation. Cell, 2011, 144, 646-674
154. Warburg, O. On Respiratory impairment in cancer cells. Science, 1956, 124, 269-270
155. Zheng, J. Energy metabolism of cancer: glycolysis versus oxidative phosphorylation (Review). Oncol. Lett., 2012, 4, 1151-1157
156. Fogg, V. C.; Lanning, N. J.; Mackeigan, J. P. Mitochondria in cancer: at the crossroads of life and death. Chin. J. Cancer, 2011, 30, 526-539
157. Sun, Y.; Zhao, X.; Zhou, Y.; Hu, Y. miR-124, miR-137 and miR-340 regulate colorectal cancer growth via inhibition of the warburg effect. Oncol. Rep., 2012, 28, 1346-1352
158. Kefas, B.; Comeau, L.; Erdle, N.; Montgomery, E.; Amos, S.; Purow, B. Pyruvate Kinase M2 Is a target of the tumor-suppressive microRNA-326 and regulates the survival of glioma Cells. Neuro Oncol., 2010, 12, 1102-1112
159. Zhang, H.; Bosch-Marce, M.; Shimoda, L. A.; Tan, Y. S.; Baek, J. H.; Wesley, J. B.; Gonzalez, F. J.; Semenza, G. L. Mitochondrial autophagy is an HIF-1-dependent adaptive mmetabolic response to hypoxia. J. Biol. Chem., 2008, 283, 10892-10903.